In an Era of
Real-World Evidence

You Need Value-Building Platforms

xIQ Volume-to-Value (V2V) Solutions

What We Do and What's in It for You


  • The xIQ Family of Companies helps clinical breakthroughs and best practices gain their rightful place at the forefront of the U.S. healthcare industry. 
  • We're a close-knit team of professionals who deliver market access, market messaging, and market engagement solutions to pioneering BioPharma, MedTech, MedFood, Community Care, Healthcare, Self-Care, and Health Plan Purchasing organizations.
  • Our solutions are essential for chief officers, senior executives, and value-focused professionals embracing healthcare's volume-to-value (V2V) transition.
  • We're best known for our next-generation, value-focused (1) access, hub, and wraparound services; (2) pharmaceutical messaging analytics; and (3) key opinion leader (KOL) visualization platforms.
  • We help ensure our clients' products, services, and solutions are backed by real-world data (RWD), real-world evidence (RWE), and compelling value dossiers for health technology assessment (HTA) authorities. 
  • Our approach is unique in applying the socially responsible, future-creating principles and practices of Peter F. Drucker to life science, social science, and data science innovations.
  • What differentiates our clients from others in the industry is their willingness to be held accountable for the performance, outcomes, and impacts of their solutions.
  • They welcome real-world data (RWD) and real-world evidence (RWE) collaborations, value-based contracting (VBC) agreements, and outcomes-based compensation (OBC) opportunities as a way to drive differential value and increase revenue, earnings growth, and competitiveness through the V2V transition.
  • They share our view that individuals, organizations, and communities flourish when they (1) lead with innovation, (2) help ethical customers become especially successful, and (3) contribute to a better functioning society.
  • For these "good actors" in U.S. healthcare, xIQ improves product development and commercialization strategies, providing support ranging from product portfolio reevaluations to post-market surveillance programs focused on real-world results (RWR).
  • With our support, clients' products, services, and solutions meet today's new gold standard for real-world value (RWV): improving the wellbeing, productive capacity, and socioeconomic status of individuals, organizations, and communities. 
  • If you're a chief officer, senior executive, or value-focused professional who is aware of the volume-to-value (V2V) transition and needs targeted expertise with the right platforms for value creation, then count on us.
  • We'll deliver the analytics, strategy, and support services you need to lead the field.

Find out more

Refocus market, corporate, and product development


  • Create scalable, sustainable, and high-value business models to achieve favorable individual, organizational, and societal results.
  • Tie compensation to “greater good” endpoints and lead the volume-to-value (V2V) transition.
  • Scale solutions across targeted health plans, beneficiary subpopulations, and sites of service.
  • Assure access to high quality, cost-effective care for appropriate covered lives in appropriate settings at appropriate times.
  • Compile real-world data (RWD) and real-world evidence (RWE) through next-gen access, hub, and wraparound (AHW) services.
  • Reduce the incidence, prevalence, and cost of targeted diseases, comorbidities, and complications.

Analytics and Platform-as-a-Service Solutions

Improve product performance, outcomes, and impacts


  • Improve economic, clinical, and humanistic outcomes (ECHOs).
  • Achieve the Triple/Quadruple Aim endpoints of reduced per capita costs, improved population health, and enhanced patient/provider experiences.
  • Support the United Nations’ Sustainable Development Goals, especially SDG #3: Health.
  • Support World Health Organization (WHO) priorities.
  • Enhance the wellbeing, productive capacity, and socioeconomic status of individuals, organizations, and communities.
  • Enable sustainable and increasingly broad-based human flourishing, contributions, and socioeconomic lift.
  • Contribute to a better functioning U.S. and global society.

Value-Based Strategy and Hands-On Support

Lead the Volume-to-Value Transition

Analytics, Strategy, and Support Services



 ReimbursementIQ is an analytics, strategy, and support-services firm that reduces the incidence, prevalence, and cost of diseases and other health challenges by (1) collecting real-world data (RWD) and building real-world evidence (RWE) through access, hub, and wraparound (AHW) solutions (so patients benefit more fully from the healthcare industry’s most safe, effective, and cost-saving products and services); (2) documenting improved economic, clinical, and humanistic outcomes (ECHOs) and Triple/Quadruple Aim successes to elicit evidence-based coverage, coding, and payment policies from health plan purchasers, third-party payers, and capitated providers; and (3) facilitating value-based contracting (VBC) and  outcomes-based compensation (OBC) toward 360-degree impact accountability.

Find out more

Voxx Analytics


Voxx Analytics is a platform-as-a-service (PaaS) solution provider that delivers real-world insight so life science decision makers, content developers, and practice drivers can properly educate, engage, and empower socially responsible policymakers, peer influencers, and practitioners; ensuring medical breakthroughs and best practices can more rapidly reduce the incidence, prevalence, and cost of diseases and other adverse conditions. Voxx provides advanced analytics, visualization platforms, and support services to help these market leaders put critical insight into practice, resulting in greater real-world evidence (RWE) of value, including Triple/Quadruple Aim endpoints (of reduced per capita costs, improved population health, and enhanced patient and provider experiences).

Find out more

Market Access | Market Messaging | Market Engagement

xIQ Affiliates



The Institute for Healthcare Advancement (IHA) is a not-for-profit, 501(c)(3) public benefit charity that empowers programs, professionals, and patients to achieve better health outcomes. Targeting systemic barriers to empowerment, IHA facilitates and promotes breakthroughs and best practices that favorably influence social determinants of health (SDoHs), especially health literacy. Within the health, education, and social services sectors, IHA produces content, convenings, and commercialization opportunities for plain language solutions at the level of community care, healthcare, and self-care. IHA’s ultimate goals are to (1) remove barriers to health equity; (2) promote culturally competent care; and (3) enhance the wellbeing, productive capacity, and socioeconomic status of individuals, organizations, and communities in the U.S. and abroad.

Central IQ


Central IQ is a social-benefit and earnings-acceleration firm that delivers market, corporate, and product development services to help innovators, entrepreneurs, and executives jumpstart revenues, earnings, and competitiveness in the health, education, and social-services sectors around solutions that improve the wellbeing, productive capacity, and socioeconomic status of individuals, organizations, and communities.



SYFR is a strategic revenue cycle management firm that works with providers pushing the edge of their specialties. By understanding key revenue drivers and obstacles in healthcare, SYFR reduces time-consuming and costly activities that plague those dependent on medical billing, coding, and payment precedents. With knowledge of value-based contracting, evidence-based coding, and impact-accountable billing, SYFR is leading the field in outcomes-based compensation (OBC).